Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Amortization of Deferred Charges: 2014-2018

Historic Amortization of Deferred Charges for Astria Therapeutics (ATXS) over the last 5 years, with Dec 2018 value amounting to $37,000.

  • Astria Therapeutics' Amortization of Deferred Charges fell 103.70% to -$1,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $37,000, marking a year-over-year decrease of 76.13%. This contributed to the annual value of $37,000 for FY2018, which is 76.13% down from last year.
  • Latest data reveals that Astria Therapeutics reported Amortization of Deferred Charges of $37,000 as of FY2018, which was down 76.13% from $155,000 recorded in FY2017.
  • Astria Therapeutics' 5-year Amortization of Deferred Charges high stood at $293,000 for FY2015, and its period low was $37,000 during FY2018.
  • Moreover, its 3-year median value for Amortization of Deferred Charges was $155,000 (2017), whereas its average is $156,333.
  • As far as peak fluctuations go, Astria Therapeutics' Amortization of Deferred Charges surged by 295.95% in 2015, and later tumbled by 76.13% in 2018.
  • Over the past 5 years, Astria Therapeutics' Amortization of Deferred Charges (Yearly) stood at $74,000 in 2014, then soared by 295.95% to $293,000 in 2015, then decreased by 5.46% to $277,000 in 2016, then crashed by 44.04% to $155,000 in 2017, then plummeted by 76.13% to $37,000 in 2018.